Table 4.
Comparison to other studies: the improvement over chance and percentage of days used in the inference phase for each patient. We compare the performance of our system with results reported in (Cook et al., 2013) and (Karoly et al., 2017).
Patient number | This study, mean IoC in % | This study, % tested | Cook et al., mean IoC in % | Cook et al., % tested | Karoly et al., mean IoC in % | Karoly et al., % tested | Circadian only, mean IoC in % (Karoly et al., 2017) | Circadian only, % tested (Karoly et al., 2017) |
---|---|---|---|---|---|---|---|---|
1 | 45·0 | 96·1 | 60 | 6·1 | 34 | 74·0 | 7 | 74·0 |
2 | 64·1 | 87·6 | 69 | 10·4 | – | – | – | – |
3 | 18·3 | 94·6 | 16 | 34·8 | 26 | 64·2 | 7 | 64·2 |
8 | 45·2 | 94·6 | 34 | 20·1 | 48 | 64·2 | 30 | 64·2 |
9 | 40·5 | 92·4 | 6 | 29·8 | 34 | 49·4 | 17 | 49·4 |
10 | 35·6 | 92·0 | 34 | 31·3 | 35 | 46·5 | 19 | 46·5 |
11 | 60·2 | 95·8 | 24 | 4·1 | 43 | 72·3 | 28 | 72·3 |
13 | 50·3 | 96·0 | 22 | 11·1 | 48 | 73·2 | 33 | 73·2 |
14 | 39·7 | 47·2 | 97 | 12·2 | – | – | – | – |
15 | 23·9 | 93·6 | 30 | 3·3 | 19 | 57·1 | 30 | 57·1 |